SWITZERLAND |SW |CHF
|Public Float||14.03M||P/E Ratio||-|
|% Short of Float||-||Dividend (Yield)||-|
|Held by Insiders||7.00%||Ex-Dividend Date|
|Held by Institutions||31.50%||IPO Date||-|
|Dec 20||Dec 19||Dec 18|
|Jun 21||Mar 21||Dec 20|
|Sep 27, 2021||CHF1.50||CHF1.50||CHF1.46||CHF1.48||-1.67%||14.90K|
Last quarter (ended on June 30 ,2021) Addex therapeutics generated a net income of CHF-4.69M, representing a 33.59% decrease compared to the same quarter a year before (ended on June 30 ,2020).
Last fiscal year (ended on December 31 ,2020) Addex therapeutics generated a net income of CHF-12.86M, representing a 13.00% decrease compare to the previous fiscal year (ended on December 31 ,2019).
View More Details on Addex therapeutics's “Financials” Section
For the last quarterly earnings period (ended on June 30, 2021) ADXN reported CHF-0.14 EPS for the quarter.
View More Details on Addex therapeutics's 'Earnings' Section
Addex therapeutics trades on the SIX Swiss stock market in Switzerland under the ticker symbol "ADXN". Addex therapeutics’s stock symbol can also be displayed as "SWX:ADXN".
Addex therapeutics (SWX:ADXN) is owned by 31.50% institutional shareholders and by 7.00% insiders. The rest is owned by the public.
Explore More Details on Addex therapeutics's “Ownership” Section
Addex therapeutics's key executive team includes the following managers:
Addex therapeutics (SWX:ADXN) is classified under the "Healthcare" sector and under the "Biotechnology" industry.
Currently the number of employees working for Addex therapeutics is 27.
Addex therapeutics (SWX:ADXN) is headquartered in Switzerland.
Addex therapeutics’s mailing address is Chemin des Mines, 9, Geneva, Switzerland, 1202.
The company’s phone number is 41 22 884 1555.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.